BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9619910)

  • 1. Thymoma associated with rheumatoid arthritis after D-penicillamine treatment.
    Tani K; Matsunaga K; Katoh K; Kawai T; Ueda A; Kase M; Lie JT
    Br J Rheumatol; 1998 Apr; 37(4):472-3. PubMed ID: 9619910
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymoma associated with rheumatoid arthritis in a patient taking methotrexate.
    Colburn KK; Cao JD
    J Rheumatol; 1986 Apr; 13(2):437-9. PubMed ID: 3723503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of tiopronin following D-penicillamine toxicity in a patient with rheumatoid arthritis.
    Matsukawa Y; Saito N; Nishinarita S; Horie T; Ryu J
    Clin Rheumatol; 1998; 17(1):73-4. PubMed ID: 9586686
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myasthenia gravis caused by D-penicillamine].
    Sanz Gallego PJ; Pérez Sánchez FC; López Vázquez A; Salgado Palacio D
    Aten Primaria; 1996 Mar; 17(5):364-5. PubMed ID: 8722166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ; Soubrier M; Bouchet F; Kemeny JL; Lhopitaux R; Bussière JL; Sauvezie B
    Rev Neurol (Paris); 1992; 148(3):207-11. PubMed ID: 1604135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine-induced myositis in rheumatoid arthritis.
    Chappel R; Willems J
    Clin Rheumatol; 1996 Jan; 15(1):86-7. PubMed ID: 8929785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillamine in the etiology of bullous pemphigoid.
    Weller R; White MI
    Ann Pharmacother; 1998 Dec; 32(12):1368. PubMed ID: 9876821
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical signs for the general dental practitioner. Case 88. D-Penicillamine rash.
    Bain S; Eligar VS
    Dent Update; 2011 Oct; 38(8):577. PubMed ID: 22128637
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins.
    Tóth GG; Jonkman MF
    Br J Dermatol; 1999 Sep; 141(3):583-5. PubMed ID: 10583082
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
    De La Mata J; Blanco FJ; Gómez-Reino JJ
    Ann Rheum Dis; 1995 Nov; 54(11):881-5. PubMed ID: 7492236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
    Kim HA; Song YW
    Rheumatol Int; 1997; 17(1):5-9. PubMed ID: 9194208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports.
    Lehuédé G; Toussirot E; Despaux J; Michel F; Wendling D
    Joint Bone Spine; 2002 Jun; 69(4):406-8. PubMed ID: 12184439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressive glomerulonephritis with D-penicillamine.
    Nanke Y; Akama H; Terai C; Kamatani N
    Am J Med Sci; 2000 Dec; 320(6):398-402. PubMed ID: 11149553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.
    Mathieson PW; Peat DS; Short A; Watts RA
    Nephrol Dial Transplant; 1996 May; 11(5):863-6. PubMed ID: 8671912
    [No Abstract]   [Full Text] [Related]  

  • 15. D-penicillamine-induced pemphigus successfully treated with combination therapy of mizoribine and prednisolone.
    Sugita K; Hirokawa H; Izu K; Tokura Y
    J Dermatolog Treat; 2004 Jul; 15(4):214-7. PubMed ID: 15764033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of rheumatoid arthritis associated with Hashimoto's thyroiditis and thymoma.
    Zou L; Xiong Z; Dun Y; Xiong Y
    Int J Rheum Dis; 2017 Nov; 20(11):1792-1793. PubMed ID: 25307507
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interstitial lung disease in rheumatoid arthritis].
    Uno-Komase Y; Azuma T
    Nihon Rinsho; 1990 Mar; 48(3):525-9. PubMed ID: 1972415
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pleuropulmonary manifestations of rheumatoid arthritis].
    Gayraud M; Guillevin L
    Ann Med Interne (Paris); 1990; 141(5):437-46. PubMed ID: 1979479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.